Purdue University scientists have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung ...

Novocure (NASDAQ: NVCR) announced today that Optune Lua® has received a CE (Conformité Européenne) Mark for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) ...

Veteran actress Sharmila Tagore's early-stage lung cancer diagnosis has brought attention to zero-stage lung cancer, also ...

In the Phase III DeLLphi-304 trial, patients with small cell lung cancer administered Imdelltra achieved a statistically ...

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung ...

A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due ...

The regulatory approval in the EU comes approximately six months after Novocure secured FDA approval of the system.

If you or a loved one has recently received a diagnosis of non-small cell lung cancer, here are 10 terms you’ll want to know. Non-small cell lung cancer (NSCLC) and the many terms related to it ...

The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced non-small cell lung cancer. The first patient has been dosed in the phase 3 ...

Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.